Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study

Reynalda Córdova; Ana-Lucia Mayén; Viktoria Knaze; Elom Kouassivi Aglago; Casper Schalkwijk; Karl-Heinz Wagner; Kim Overvad; Anne Tjønneland; Cecilie Kyrø; Verena Andrea Katzke; Charlotte Le Cornet; Matthias Bernd Schulze; Anna Birukov; Domenico Palli; Sara Grioni; Fabrizio Pasanisi; Alberto Catalano; Torkjel Manning Sandanger; Inger Torhild Gram; Guri Skeie; Marta Crous-Bou; Esther Molina-Montes; Pilar Amiano; Sandra Milena Colorado-Yohar; Eva Ardanaz; Isabel Drake; Jonas Manjer; Ingegerd Johansson; Anders Esberg; Aurora Perez-Cornago; Elisabete Weiderpass; Mazda Jenab; Heinz Freisling

doi:10.1002/cac2.12343

Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study

Reynalda Córdova, Ana-Lucia Mayén, Viktoria Knaze, Elom Kouassivi Aglago, Casper Schalkwijk, Karl-Heinz Wagner, Kim Overvad, Anne Tjønneland, Cecilie Kyrø, Verena Andrea Katzke, Charlotte Le Cornet, Matthias Bernd Schulze, Anna Birukov, Domenico Palli, Sara Grioni, Fabrizio Pasanisi, Alberto Catalano, Torkjel Manning Sandanger, Inger Torhild Gram, Guri SkeieMarta Crous-Bou, Esther Molina-Montes, Pilar Amiano, Sandra Milena Colorado-Yohar, Eva Ardanaz, Isabel Drake, Jonas Manjer, Ingegerd Johansson, Anders Esberg, Aurora Perez-Cornago, Elisabete Weiderpass, Mazda Jenab, Heinz Freisling^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1041-1045
Number of pages	5
Journal	Cancer Communications
Volume	42
Early online date	4 Aug 2022
DOIs	https://doi.org/10.1002/cac2.12343
Publication status	Published - Oct 2022

Keywords

END-PRODUCTS
End-products

Access to Document

10.1002/cac2.12343Licence: CC BY-NC-ND

Cite this

Córdova, R., Mayén, A.-L., Knaze, V., Aglago, E. K., Schalkwijk, C., Wagner, K.-H., Overvad, K., Tjønneland, A., Kyrø, C., Katzke, V. A., Cornet, C. L., Schulze, M. B., Birukov, A., Palli, D., Grioni, S., Pasanisi, F., Catalano, A., Sandanger, T. M., Gram, I. T., ... Freisling, H. (2022). Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study. Cancer Communications, 42, 1041-1045. https://doi.org/10.1002/cac2.12343

@article{0279faa97bbf43db94fea935b8f05664,

title = "Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study",

keywords = "END-PRODUCTS, End-products",

author = "Reynalda C{\'o}rdova and Ana-Lucia May{\'e}n and Viktoria Knaze and Aglago, {Elom Kouassivi} and Casper Schalkwijk and Karl-Heinz Wagner and Kim Overvad and Anne Tj{\o}nneland and Cecilie Kyr{\o} and Katzke, {Verena Andrea} and Cornet, {Charlotte Le} and Schulze, {Matthias Bernd} and Anna Birukov and Domenico Palli and Sara Grioni and Fabrizio Pasanisi and Alberto Catalano and Sandanger, {Torkjel Manning} and Gram, {Inger Torhild} and Guri Skeie and Marta Crous-Bou and Esther Molina-Montes and Pilar Amiano and Colorado-Yohar, {Sandra Milena} and Eva Ardanaz and Isabel Drake and Jonas Manjer and Ingegerd Johansson and Anders Esberg and Aurora Perez-Cornago and Elisabete Weiderpass and Mazda Jenab and Heinz Freisling",

note = "Funding Information: Reynalda C{\'o}rdova is a recipient of a DOC Fellowship of the Austrian Academy of Sciences. This study was funded by the Fondation de France (FDF, grant no. 00081166, HF and RC, and FDF grant no. 00089811, ALM). MJ and EA acknowledge funding by the Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund (WCRF) International grant programme (WCRF 2015‐1391, PI Dr. Mazda Jenab, International Agency for Research on Cancer). Funding Information: Reynalda C{\'o}rdova is a recipient of a DOC Fellowship of the Austrian Academy of Sciences. This study was funded by the Fondation de France (FDF, grant no. 00081166, HF and RC, and FDF grant no. 00089811, ALM). MJ and EA acknowledge funding by the Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund (WCRF) International grant programme (WCRF 2015-1391, PI Dr. Mazda Jenab, International Agency for Research on Cancer). The authors would like to thank the EPIC study participants and staff for their valuable contribution to this research. The authors would also like to especially thank Mr. Bertrand Hemon and Ms. Corinne Casagrande for preparing the EPIC databases. We acknowledge the use of data from the EPIC-France cohort, PI Gianluca Severi; the EPIC-Ragusa cohort, PI Rosario Tumino; the Prospect-EPIC Utrecht cohort, PI Roel Vermeulen; the EPIC-Asturias cohort, PI J. Ram{\'o}n Quir{\'o}s; the EPIC-Norfolk cohort, PI Nick Wareham; and the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, for their contribution and ongoing support to the EPIC Study.",

year = "2022",

month = oct,

doi = "10.1002/cac2.12343",

language = "English",

volume = "42",

pages = "1041--1045",

journal = "Cancer Communications",

issn = "2523-3548",

publisher = "BioMed Central Ltd",

}

Córdova, R, Mayén, A-L, Knaze, V, Aglago, EK, Schalkwijk, C, Wagner, K-H, Overvad, K, Tjønneland, A, Kyrø, C, Katzke, VA, Cornet, CL, Schulze, MB, Birukov, A, Palli, D, Grioni, S, Pasanisi, F, Catalano, A, Sandanger, TM, Gram, IT, Skeie, G, Crous-Bou, M, Molina-Montes, E, Amiano, P, Colorado-Yohar, SM, Ardanaz, E, Drake, I, Manjer, J, Johansson, I, Esberg, A, Perez-Cornago, A, Weiderpass, E, Jenab, M & Freisling, H 2022, 'Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study', Cancer Communications, vol. 42, pp. 1041-1045. https://doi.org/10.1002/cac2.12343

TY - JOUR

T1 - Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites

T2 - A multinational cohort study

AU - Córdova, Reynalda

AU - Mayén, Ana-Lucia

AU - Knaze, Viktoria

AU - Aglago, Elom Kouassivi

AU - Schalkwijk, Casper

AU - Wagner, Karl-Heinz

AU - Overvad, Kim

AU - Tjønneland, Anne

AU - Kyrø, Cecilie

AU - Katzke, Verena Andrea

AU - Cornet, Charlotte Le

AU - Schulze, Matthias Bernd

AU - Birukov, Anna

AU - Palli, Domenico

AU - Grioni, Sara

AU - Pasanisi, Fabrizio

AU - Catalano, Alberto

AU - Sandanger, Torkjel Manning

AU - Gram, Inger Torhild

AU - Skeie, Guri

AU - Crous-Bou, Marta

AU - Molina-Montes, Esther

AU - Amiano, Pilar

AU - Colorado-Yohar, Sandra Milena

AU - Ardanaz, Eva

AU - Drake, Isabel

AU - Manjer, Jonas

AU - Johansson, Ingegerd

AU - Esberg, Anders

AU - Perez-Cornago, Aurora

AU - Weiderpass, Elisabete

AU - Jenab, Mazda

AU - Freisling, Heinz

N1 - Funding Information: Reynalda Córdova is a recipient of a DOC Fellowship of the Austrian Academy of Sciences. This study was funded by the Fondation de France (FDF, grant no. 00081166, HF and RC, and FDF grant no. 00089811, ALM). MJ and EA acknowledge funding by the Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund (WCRF) International grant programme (WCRF 2015‐1391, PI Dr. Mazda Jenab, International Agency for Research on Cancer). Funding Information: Reynalda Córdova is a recipient of a DOC Fellowship of the Austrian Academy of Sciences. This study was funded by the Fondation de France (FDF, grant no. 00081166, HF and RC, and FDF grant no. 00089811, ALM). MJ and EA acknowledge funding by the Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund (WCRF) International grant programme (WCRF 2015-1391, PI Dr. Mazda Jenab, International Agency for Research on Cancer). The authors would like to thank the EPIC study participants and staff for their valuable contribution to this research. The authors would also like to especially thank Mr. Bertrand Hemon and Ms. Corinne Casagrande for preparing the EPIC databases. We acknowledge the use of data from the EPIC-France cohort, PI Gianluca Severi; the EPIC-Ragusa cohort, PI Rosario Tumino; the Prospect-EPIC Utrecht cohort, PI Roel Vermeulen; the EPIC-Asturias cohort, PI J. Ramón Quirós; the EPIC-Norfolk cohort, PI Nick Wareham; and the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, for their contribution and ongoing support to the EPIC Study.

PY - 2022/10

Y1 - 2022/10

KW - END-PRODUCTS

KW - End-products

U2 - 10.1002/cac2.12343

DO - 10.1002/cac2.12343

M3 - Comment/Letter to the editor

C2 - 35924960

SN - 2523-3548

VL - 42

SP - 1041

EP - 1045

JO - Cancer Communications

JF - Cancer Communications

ER -